Ochiai Atsushi, Fritsche Herbert A, Babaian R Joseph
Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1439, USA.
Urology. 2005 Oct;66(4):819-23. doi: 10.1016/j.urology.2005.04.040.
To assess the correlation between age, height, body weight, body mass index, body surface area (BSA), prostate volume, and prostate-specific antigen (PSA) level, and to determine the significant factors for predicting the PSA level in men with a low risk of having prostate cancer.
Men who had undergone at least one ultrasound-guided extended prostate biopsy at the M.D. Anderson Cancer Center from 1998 to 2003 and were proven, on pathologic examination, to be without cancer were included in this study. All patients underwent clinical evaluations, including digital rectal examination, serum PSA determination, transrectal ultrasound examination, and anthropometric measurements. The relationship between the clinical parameters and PSA level was examined by the Mann-Whitney U test and determination of the Pearson correlation coefficient.
A total of 653 men were eligible for analysis in our study. The median age was 62.0 years; the median prostate volume was 48.3 cm3; and the median PSA level was 5.5 ng/mL. The PSA level correlated with age (P < 0.001) and prostate volume (P < 0.001), but not with height, body weight, body mass index, or BSA. The prostate volume correlated with age (P < 0.001), body weight (P < 0.001), body mass index (P < 0.01), and BSA (P < 0.01), but not with height. Multivariate analysis revealed that prostate volume and BSA were significant factors for predicting the PSA level.
Of the variables tested, prostate volume was most significantly related to the PSA level. The anthropometric parameters were not directly associated with the PSA level, but were associated with the prostate volume. Our findings suggest that differences in the PSA level may be influenced by body size, if the prostate volume is held constant in men with a low risk of having prostate cancer.
评估年龄、身高、体重、体重指数、体表面积(BSA)、前列腺体积和前列腺特异性抗原(PSA)水平之间的相关性,并确定预测前列腺癌低风险男性PSA水平的显著因素。
纳入1998年至2003年在MD安德森癌症中心接受至少一次超声引导下扩大前列腺活检且病理检查证实无癌症的男性。所有患者均接受临床评估,包括直肠指检、血清PSA测定、经直肠超声检查和人体测量。通过Mann-Whitney U检验和Pearson相关系数测定来检查临床参数与PSA水平之间的关系。
共有653名男性符合我们研究的分析条件。中位年龄为62.0岁;中位前列腺体积为48.3 cm³;中位PSA水平为5.5 ng/mL。PSA水平与年龄(P < 0.001)和前列腺体积(P < 0.001)相关,但与身高、体重、体重指数或BSA无关。前列腺体积与年龄(P < 0.001)、体重(P < 0.001)、体重指数(P < 0.01)和BSA(P < 0.01)相关,但与身高无关。多因素分析显示前列腺体积和BSA是预测PSA水平的显著因素。
在所测试的变量中,前列腺体积与PSA水平的相关性最为显著。人体测量参数与PSA水平无直接关联,但与前列腺体积有关。我们的研究结果表明,在前列腺癌低风险男性中,如果前列腺体积保持不变,PSA水平的差异可能受体型影响。